New medical devices need to be manually tested for safety and efficacy several times throughout their development cycle. But is it possible to eliminate the drawbacks of time, costs, and possible safety risks while maintaining the advantages of in vivo evaluation? One way to achieve this could be in silico medicine, which uses virtual human models to replace their physical counterparts in testing and clinical evaluation of new medical devices.
In the white paper Dr. Visa Suomi, Medical Devices Industry Manager at MathWorks, discusses how medtech companies can take advantage of computational modelling and simulation in medical devices R&D and stay competitive in the future.
Click here to download the white paper.
Author
Dr. Visa Suomi is the Medical Devices Industry Manager at MathWorks. He has over 10 years of international experience in the life sciences and healthcare sector, with an interdisciplinary background from the medical technology industry, academia, and clinical research. He holds a doctoral degree (DPhil in Healthcare Innovation) from the University of Oxford, UK, with the focus on translating academic and clinical research into commercial applications.
